 Notes from the East
Woods musings on opportunities in the life science
marketplace
February 2010
|
|
|
|
Greetings!
|
Flocking to a carcass is not for everyone. Please have a read and feel free to let me know what you think.
We would also like to extend a sincere thank you to all of our clients, colleagues, and friends that have helped us over the years as we celebrate the 5 year anniversary of our founding. Thanks and we look forward to the next 5.
Regards,
Paul Danis Founder and Principal
|
|
|
|
|
|
Carcasses and Niches
|
I was cross country skiing last weekend, enjoying a crisp
winter afternoon, when I came across a flock of birds picking over a carcass. Rather than gather seeds peacefully from the
millions of pine cones in the forest, these creatures chose to battle each
other for a few scraps of coyote (or whatever the brown-furred thing used to be.) It reminded me of many life science markets
where companies flock to certain segments all hoping to get a big chunk. What they often get are just a few nibbles. The key thing here is choosing where to get
your nourishment (sales) - do you go where everyone is and try to battle it
out, or do you find a cache that you can have all to yourself.
Many of the companies I work with are faced with this common
dilemma - own a niche or battle for a piece of the big pie. With many new technologies and products
coming to the market, this question must be answered quite regularly, and the
most common answer is - 'both.' It is
human nature to go after any potential business for your products or
services. But to really succeed you
usually need to let go of a few areas to put your efforts where you will be
most efficient.
So what can you do to get focused? First you need to agree that a focused effort
will provide a better pathway toward growth and increased profits. If the birds had flown all over the place
whenever there was a hint of food, they would have exhausted their energy and
turned into fuzzy ice cubes. They have
to carefully choose the nutritional sources that give the most energy and are
readily accessible. In essence they
figured out the return on their investment in their tiny little heads.
Companies do this as well, based on wonderful rosy
forecasts. The biggest challenge,
though, comes in honestly assessing what it would take to capture that amount
of business. Here are some of the things
that must be considered when deciding where to sell your products.
- Channels - Can you get to the people who have the problem
your product solves. And can you do what
is necessary to help them be successful with it.
So when it is time to choose your source of nutrition be
sure to consider carefully what will best help you grow. Simply going wherever there is sustenance may
not be the wisest approach. Take a
careful look at the options and decide what will nourish you the
best. You don't what to chase every opportunity and run out of
energy before your reach your next meal.
|
Life Science Market Update
|
|
Index
|
January Value
|
Change 12mo.
|
12 mo. High
|
12 mo. Low
|
|
EC BioTools
|
631
|
45%
|
639
|
411
|
|
EC BigPharma
|
789
|
16%
|
796
|
587
|
|
EC Biotech
|
582
|
16%
|
582
|
446
|
Biotech is the star of this month, rising to a 12 month high while the Tools and Pharma were off slightly. Illimina outshone its brethren with a 20% appreciation for the month on news of its new machine for $10,000 DNA sequencing as well as strong revenue. Otherwise declines led advances 4 to 1 for Tools while Pharma was at 2-1. Biotech's strength was evident as advances led declines 2 to 1.
EC BioIndex January 2010
---------------------
Many of the life science
indices currently available are a mixture of various types of companies. In
order to better assess the situation in the different segments, Eastwoods
Consulting has created these price-weighted indices for the sectors of large
pharmaceutical companies, biotech companies, and life science research tools
companies.
-
EC BioTools Index - A, ACCL, AFFX, BEC, BIO, BRKR,
CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL,
TMO, VARI, WAT
-
EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, LUN, ABT,
LLY, AZN, WYE, BMY, NVO, BAX, TEVA, KG, ROG.VX
-
EB Biotech Index - AMGN, GENZ, BIIB, CEPH, GILD,
BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, VRTX, THRX, HGSI, SGMO, NKTR
-
Prices are
taken at the close of each month. YTD is the year to date change taken from the end of December, 2008.
|
|
| About Eastwoods Consulting
|
Translating Innovations into Profits for the Life Science IndustrysmEastwoods Consulting helps life science companies grow their businesses. Please visit our web site or contact us to learn more about how we help companies succeed in competitive markets.
|
Copyright © 2010, Eastwoods Consulting. This
publication may be freely redistributed in full or in part as long as full
attribution including our contact information and web address, are included. Eastwoods is a registered servicemark of Eastwoods Consultng.
|
|
|
|
|